IHI
iShares U.S. Medical Devices ETF·Financial Services
53.24
1.041%(−0.56)
Market ClosedLast Updated: — ET
52W L: $52.1352W H: $64.71
IHI NEWS
seekingalpha.com
Mar 23
IHI: Pullback Creates A Buying Opportunity In High-Growth MedTech
I rate iShares US Medical Devices ETF a buy, as its recent selloff offers an attractive entry into industry-leading medical device innovators. IHI's top holdings—Abbott Laboratories, Intuitive Surgical, and Boston Scientific—drive growth through strong fundamentals, product innovation, and exposure to secular healthcare trends. Despite higher fees (0.38%) and volatility, IHI's concentrated exposure to medical devices positions it for long-term capital appreciation over more diversified healthcare ETFs.
zacks.com
Mar 5
Buy the Dip in These Top-Ranked ETFs
Market volatility from Iran tensions has created dip-buying chances. Here are 5 ETFs across tech, semis, dividends, healthcare and financials.
zacks.com
Feb 23
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?
Launched on May 1, 2006, the iShares U.S. Medical Devices ETF (IHI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Medical Devices segment of the equity market.
defenseworld.net
Feb 19
iShares U.S. Medical Devices ETF $IHI Shares Sold by Ameritas Advisory Services LLC
Ameritas Advisory Services LLC trimmed its holdings in shares of iShares U.S. Medical Devices ETF (NYSEARCA:IHI) by 93.2% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,069 shares of the company's stock after selling 28,474 shares during
fool.com
Feb 11
Sector Alert: 4 Healthcare ETFs Poised for Explosive Growth Now
Over the past three years, healthcare has been among the worst-performing sectors. 2026's market rotation away from tech is bringing new life to more defensive areas of the market.
defenseworld.net
Feb 2
Transcend Capital Advisors LLC Cuts Stock Position in iShares U.S. Medical Devices ETF $IHI
Transcend Capital Advisors LLC decreased its position in shares of iShares U.S. Medical Devices ETF (NYSEARCA:IHI) by 33.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 22,755 shares of the company's stock after selling 11,429 shares during the period.
